These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6120452)

  • 1. Effects of narcotics and narcotic antagonists on affective disorders, schizophrenia and serum neurohormones.
    Judd LL; Janowsky DS
    Mod Probl Pharmacopsychiatry; 1981; 17():213-25. PubMed ID: 6120452
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioral and neuroendocrine effects of opioid receptor agonists in psychopathologic states.
    Judd LL; Risch SC; Segal DS; Janowsky DS; Huey LY
    Psychiatr Clin North Am; 1983 Sep; 6(3):393-402. PubMed ID: 6359090
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavioral effects of opioid receptor antagonists in psychopathologic states.
    Janowsky DS; Judd LL; Huey LY; Risch SC; Segal DS
    Psychiatr Clin North Am; 1983 Sep; 6(3):403-14. PubMed ID: 6316300
    [No Abstract]   [Full Text] [Related]  

  • 4. [Etiologic and therapeutic significance of endorphins in endogenous psychoses].
    Naber D
    Nervenarzt; 1983 Nov; 54(11):573-7. PubMed ID: 6318141
    [No Abstract]   [Full Text] [Related]  

  • 5. [Endorphins in psychiatry].
    Lajeunesse C; Villeneuve A
    Sem Hop; 1982 Dec; 58(44):2581-7. PubMed ID: 6297051
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of naloxone in schizophrenic psychoses and manic syndromes.
    Verhoeven WM; van Praag HM; de Jong JT
    Neuropsychobiology; 1981; 7(3):159-68. PubMed ID: 7231653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid agonists and antagonists in schizophrenia.
    Barchas JD; Berger PA; Watson SJ; Akil H; Li CH
    Adv Biochem Psychopharmacol; 1980; 22():447-53. PubMed ID: 7395601
    [No Abstract]   [Full Text] [Related]  

  • 8. Naloxone treatment for five days ineffective in schizophrenia. Neuroendocrine actions of the opiate antagonist.
    Naber D; Münch U; Wissmann J; Grosse R; Ritt R; Welter D
    Acta Psychiatr Scand; 1983 Apr; 67(4):265-71. PubMed ID: 6305111
    [No Abstract]   [Full Text] [Related]  

  • 9. Endorphins in psychiatry: an overview and a hypothesis.
    Verebey K; Volavka J; Clouet D
    Arch Gen Psychiatry; 1978 Jul; 35(7):877-88. PubMed ID: 209757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research in endorphins and schizophrenia.
    Davis GC; Buchsbaum MS; Bunney WE
    Schizophr Bull; 1979; 5(2):244-50. PubMed ID: 37596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin response in tardive dyskinesia.
    Wolf ME; Bowie L; Keener S; Mosnaim AD
    Biol Psychiatry; 1982 Apr; 17(4):485-90. PubMed ID: 7082714
    [No Abstract]   [Full Text] [Related]  

  • 12. Stereospecific effects of opiate antagonists on superficial and deep nociception and on motor activity suggest involvement of endorphins on different opioid receptors.
    Ramabadran K; Jacob JJ
    Life Sci; 1979 May; 24(21):1959-69. PubMed ID: 222987
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of methadone on the behavioral and neuroendocrine responses of manic patients.
    Judd LL; Parker DC; Janowsky DS; Segal DS; Risch SC; Huey LY
    Psychiatry Res; 1982 Oct; 7(2):163-70. PubMed ID: 6959168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone, tardive dyskinesia, and endogenous beta-endorphin.
    Reker D; Anderson B; Yackulic C; Cooper TB; Banay-Schwartz M; Leon C; Volavka J
    Psychiatry Res; 1982 Dec; 7(3):321-4. PubMed ID: 6298849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of naloxone and naltrexone in different types of psychoses.
    Volavka J
    Mod Probl Pharmacopsychiatry; 1981; 17():202-12. PubMed ID: 6276726
    [No Abstract]   [Full Text] [Related]  

  • 16. Emergency naloxone for heroin overdose: naloxone is not the only opioid antagonist.
    Brewer C
    BMJ; 2006 Oct; 333(7571):754-5. PubMed ID: 17023477
    [No Abstract]   [Full Text] [Related]  

  • 17. Examining the dopamine hypotheses of schizophrenia and of mania using the prolactin response to antipsychotic drugs.
    Silverstone T; Cookson J
    Neuropharmacology; 1983 Apr; 22(4):539-41. PubMed ID: 6134252
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical studies on the role of endorphins in schizophrenia.
    Berger PA; Watson SJ; Akil H; Barchas JD
    Mod Probl Pharmacopsychiatry; 1981; 17():226-35. PubMed ID: 6276727
    [No Abstract]   [Full Text] [Related]  

  • 19. Behavioral and biological effects of acute beta-endorphin injection in schizophrenic and depressed patients.
    Pickar D; Davis GC; Schulz SC; Extein I; Wagner R; Naber D; Gold PW; van Kammen DP; Goodwin FK; Wyatt RJ; Li CH; Bunney WE
    Am J Psychiatry; 1981 Feb; 138(2):160-6. PubMed ID: 6257125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endorphins, dopamine, and schizophrenia.
    Volavka J; Davis LG; Ehrlich YH
    Schizophr Bull; 1979; 5(2):227-39. PubMed ID: 37595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.